Form 4: AbbVie Director Susan E. Quaggin Reports Acquisition of Stock Equivalent Units

Director Susan E. Quaggin reports acquisition of AbbVie stock equivalent units through director fees and dividend reinvestment.

Summary

• On December 31, 2024, Susan E. Quaggin, a director of AbbVie Inc., acquired 84 stock equivalent units as director fees.
• These units were credited to a stock equivalent unit account under a grantor trust.
• The units earn the same return as if the fees were invested in AbbVie stock and are generally paid in cash at age 65 or upon retirement from the board.
• Quaggin also acquired additional stock equivalent units through a dividend reinvestment feature, increasing her holdings to 401 units.
• The price of the stock equivalent units was $177.7.

Sentiment

Score: 7

Explanation: The document reflects a routine transaction related to director compensation, indicating a neutral to slightly positive sentiment as it demonstrates the director's continued investment in the company.

Positives

• The acquisition of stock equivalent units demonstrates the director's continued investment in AbbVie's future.
• Dividend reinvestment further increases the director's stake in the company.

Future Outlook

The stock equivalent units will be paid out in cash generally at age 65 or upon retirement from the board.

Industry Context

This filing is a routine disclosure of a director's acquisition of stock equivalent units, a common form of compensation for board members.

Comparison to Industry Standards

• Director compensation packages often include stock or stock-based awards to align their interests with shareholders.
• Stock equivalent units are a common method to provide directors with equity-like incentives without issuing actual shares.
• Companies like Pfizer, Johnson & Johnson, and Merck also utilize similar equity-based compensation for their directors.

Stakeholder Impact

• The transaction has a minor positive impact on shareholders as it aligns the director's interests with the company's performance.

Key Dates